Items Tagged ‘chimeric antigen receptor’

CAR T-cell therapy: A revolutionary new cancer treatment

October 7, 2019

CAR T-cell therapy: A revolutionary new cancer treatment

By uclahealth uclahealth

Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma. What is CAR T-cell […]

View full entry

Tags: cancer, CAR T cell therapy, chimeric antigen receptor, clinical trials, immunotherapy, innovation, research, UCLA Jonsson Comprehensive Cancer Center


What is immunotherapy?

February 11, 2019

What is immunotherapy?

By uclahealth uclahealth

Medical researchers have had breakthroughs in treating certain types of cancer by bolstering a patient’s immune system. Known as immunotherapy, or biologic therapy, it treats cancer differently than established treatments such as chemotherapy, radiation, bone marrow transplant and surgery. To date, the U.S. Food and Drug Administration (FDA) has approved immunotherapy treatments for 17 cancer […]

View full entry

Tags: blood cancer, bone marrow transplant, CAR T cell therapy, chimeric antigen receptor, engineered T cells, immune system, immunotherapy, T cell, UCLA Jonsson Comprehensive Cancer Center